The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration.
Open accessAbstract
The CDK inhibitor p21 (WAF-1/CIP-1/SDI-1) has been implicated in DNA damage-induced p53-mediated G1 arrest, as well as in physiological processes, such as cell differentiation and senescence, that do not involve p53 function. To determine the impact of p21 on normal development and cell-cycle regulation in vivo, we have generated transgenic mice that abundantly express p21 specifically in hepatocytes. During postnatal liver development, when transgenic p-21 protein becomes detectable, hepatocyte proliferation is inhibited dramatically. This disturbance causes a reduction in the overall number of adult hepatocytes, resulting in aberrant tissue organization, runted liver and body growth, and increased mortality. The transgenic p21 protein is associated with most, if not all, of the cyclin D1-CDK4 in liver but not significantly with other cyclin/CDK proteins, indicating the importance of cyclin D1-CDK4 function in normal liver development. The appearance of large polyploid nuclei in some hepatocytes indicates that p21 may also cause arrest during the G2 phase of the cell cycle. Significantly, partial hepatectomy failed to stimulate hepatocytes to proliferate in p21 transgenic animals. These results provide the first in vivo evidence that appropriate p21 levels are critical in normal development and further implicate p21 in the control of multiple cell-cycle phases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The proliferation of p21 positive hepatocytes is irreversibly inhibited49 making it unlikely that p21 positive hepatocytes contribute to regeneration here.”
From Hepatic progenitor cells of biliary origin with liver repopulation capacity (2015) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Experimental pathology of the liver
Higgins, G. (1931) · Medical Entomology and Zoology · Cited by 4,057
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Self-citationA new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,288
Inhibitors of mammalian G1 cyclin-dependent kinases.Preprint
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,242
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
G1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,675
Research works printed but not linked: 3
- 10.1128/MCB.6.12.4697 · DOI
- 1992, The liver as a stem cell lineage system., Am. J. Physiol., 263, 139
- 1994, Induction of p21 (WAF1/CIP1) during differentiation., Oncogene, 9, 3389
Cited by
Sorted by citations
Items 101–200 of 234
Expression of cyclin-dependent kinase inhibitor p21 in human liver
Crary, G. S., & Albrecht, J. H. (1998) · Hepatology · doi:10.1002/hep.510280320 · Cited by 62
Willenbring, H., Sharma, A. D., Vogel, A., Lee, A. Y., Rothfuß, A., Wang, Z., Finegold, M. J., & Grompe, M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.004 · Cited by 61
Auer, K. L., Park, J. S., Seth, P. K., Coffey, R. J., Darlington, G., Abo, A., McMahon, M., DePinho, R. A., Fisher, P. B., & Dent, P. (1998) · Biochemical Journal · doi:10.1042/bj3360551 · Cited by 59
Ring, N., Valdivieso, K., Grillari, J., Redl, H. R., & Ogrodnik, M. B. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.04.005 · Cited by 59
Longo, C. R., Patel, V. I., Shrikhande, G. V., Scali, S. T., Csizmadia, E., Daniel, S., Sun, D. W., Grey, S. T., Arvelo, M. B., & Ferran, C. (2005) · Hepatology · doi:10.1002/hep.20741 · Cited by 60
Hoeferlin, L. A., Oleinik, N. V., Krupenko, N. I., & Krupenko, S. A. (2011) · Genes & Cancer · doi:10.1177/1947601911432495 · Cited by 59
Mullany, L. K., Nelsen, C. J., Hanse, E. A., Goggin, M. M., Anttila, C. K., Peterson, M., Bitterman, P. B., Raghavan, A., Crary, G. S., & Albrecht, J. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702110200 · Cited by 59
Zeng, H., Li, D., Qin, X., Chen, P., Tan, H., Zeng, X., Li, X., Fan, X., Jiang, Y., Zhou, Y., et al. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.066969 · Cited by 59
Qiao, L., Leach, K., McKinstry, R. P., Gilfor, D., Yacoub, A., Park, J. S., Grant, S., Hylemon, P. B., Fisher, P. B., & Dent, P. (2001) · Hepatology · doi:10.1053/jhep.2001.28886 · Cited by 59
Zhang, Y., Wang, H., & Xiao, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095016 · Cited by 57
Marhenke, S., Buitrago‐Molina, L. E., Endig, J., Orlik, J., Schweitzer, N., Klett, S., Longerich, T., Geffers, R., Sánchez, A., Dorrell, C., et al. (2013) · Gut · doi:10.1136/gutjnl-2013-304829 · Cited by 57
Liao, L., Dearth, R. K., Zhou, S., Britton, O. L., Lee, A. V., & Xu, J. (2006) · Endocrinology · doi:10.1210/en.2005-1537 · Cited by 56
Effect of p21waf1/cip1 transgene on radiation induced apoptosis in T cells
Fotedar, R., Brickner, H., Saadatmandi, N., Rousselle, T., Diederich, L., Munshi, A., Jung, B. H., Reed, J. C., & Fotedar, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202693 · Cited by 55
LRP130 Protein Remodels Mitochondria and Stimulates Fatty Acid Oxidation
Liu, L., Sanosaka, M., Shi, L., Bestwick, M. L., Frey, J. H., Surovtseva, Y. V., Shadel, G. S., & Cooper, M. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.276121 · Cited by 54
STAT3 Sensitizes Insulin Signaling by Negatively Regulating Glycogen Synthase Kinase-3β
Moh, A., Zhang, W., Yu, S. S. B., Wang, J., Xu, X., Li, J., & Fu, X.-Y. (2008) · Diabetes · doi:10.2337/db06-1582 · Cited by 53
Núñez, F., Chipchase, M. D., Clarke, A. R., & Melton, D. W. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.9.1073 · Cited by 56
Lunz, J. G., Tsuji, H., Nozaki, I., Murase, N., & Demetris, A. J. (2005) · Hepatology · doi:10.1002/hep.20709 · Cited by 52
Albrecht, J. H., Rieland, B. M., Nelsen, C. J., & Ahonen, C. L. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.277.6.g1207 · Cited by 50
The Growth-Regulatory Role of p21 (WAF1/CIP1)
Gartel, A. L., & Tyner, A. L. (1998) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-72149-6_4 · Cited by 49
Proliferation-inhibiting pathways in liver regeneration
Liu, M., & Chen, P. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6613 · Cited by 49
p21 WAF-1 reorganizes the nucleus in tumor suppression
Linares‐Cruz, G., Bruzzoni‐Giovanelli, H., Alvaro, V., Roperch, J.-P., Tuynder, M., Schoëvaërt, D., Nemani, M., Prieur, S., Lethrosne, F., Piouffre, L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1131 · Cited by 49
Characterization of Premature Liver Polyploidy in Dna Repair ( Ercc1 )–Deficient Mice
Chipchase, M. D., O'Neill, M., & Melton, D. W. (2003) · Hepatology · doi:10.1053/jhep.2003.50421 · Cited by 49
Hepatocyte-specific deletion of DDB1 induces liver regeneration and tumorigenesis
Yamaji, S., Zhang, M., Zhang, J., Endo, Y., Бибикова, Е., Goff, S. P., & Cang, Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015793108 · Cited by 47
A regulatory system for target gene expression
Tsai, S. Y. (1998) · Frontiers in bioscience · doi:10.2741/a258 · Cited by 47
Atm Is Dispensable for p53 Apoptosis and Tumor Suppression Triggered by Cell Cycle Dysfunction
Liao, M.-J., Yin, C., Barlow, C., Wynshaw-Boris, A. J., & Dyke, T. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.3095 · Cited by 46
Cell cycle-mediated regulation of hepatic regeneration
Ehrenfried, J. A., Ko, T. C., Thompson, E. A., & Evers, B. M. (1997) · Surgery · doi:10.1016/s0039-6060(97)90334-2 · Cited by 45
Lamont, B. J., Visinoni, S., Fam, B. C., Kebede, M. A., Weinrich, B., Papapostolou, S., Massinet, H., Proietto, J., Favaloro, J. M., & Andrikopoulos, S. (2006) · Endocrinology · doi:10.1210/en.2005-1498 · Cited by 44
Shih, H. H., Xiu, M., Berasi, S. P., Sampson, E. M., Leiter, A. B., Paulson, K. E., & Yee, A. S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5723-5732.2001 · Cited by 44
CYCLOSPORINE INDUCES THE EXPRESSION OF THE CYCLIN INHIBITOR p21
Khanna, A. K., & Hosenpud, J. D. (1999) · Transplantation · doi:10.1097/00007890-199905150-00011 · Cited by 44
Park, J. S., Boyer, S. N., Mitchell, K. O., Gilfor, D., Birrer, M. J., Darlington, G., El‐Deiry, W. S., Firestone, G. L., Münger, K., Band, V., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.18 · Cited by 44
Additive effect of p53, p21 and Rb deletion in triple knockout primary hepatocytes
Sheahan, S., Bellamy, C. O., Treanor, L. M., Harrison, D. J., & Prost, S. (2003) · Oncogene · doi:10.1038/sj.onc.1207280 · Cited by 40
Awad, M. M., & Gruppuso, P. A. (2000) · PubMed · Cited by 40
The human ARHI tumor suppressor gene inhibits lactation and growth in transgenic mice.
Xu, F., Xia, W., Luo, R. Z., Peng, H., Zhao, S., Dai, J., Long, Y., Zou, L., Le, W., Liu, J., et al. (2000) · PubMed · Cited by 39
Serfas, M. S., Goufman, E., Feuerman, M. H., Gartel, A. L., & Tyner, A. L. (1997) · PubMed · Cited by 39
BOK promotes chemical-induced hepatocarcinogenesis in mice
Rabachini, T., Fernández‐Marrero, Y., Montani, M., Loforese, G., Sladky, V. C., He, Z., Bachmann, D., Wicki, S., Villunger, A., Stroka, D., et al. (2017) · Cell Death and Differentiation · doi:10.1038/s41418-017-0008-0 · Cited by 39
Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome
Contestabile, A., Fila, T., Cappellini, A., Bartesaghi, R., & Ciani, E. (2009) · Cell Proliferation · doi:10.1111/j.1365-2184.2009.00587.x · Cited by 39
Liver Damage using Suicide Genes
Bustos, M., Sangro, B., Alzuguren, P., Gil, A. G., Ruiz, J., Beraza, N., Qian, C., Garcı́a-Pardo, A., & Prìeto, J. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64565-8 · Cited by 38
Trautwein, C., Will, M., Kubicka, S., Rakemann, T., Flemming, P., & Manns, M. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203045 · Cited by 37
Control of mouse hepatocyte proliferation and ploidy by p53 and p53ser246 mutation in vivo
Yin, L., Ghebranious, N., Chakraborty, S., Sheehan, C. E., Ilic, Z., & Sell, S. (1998) · Hepatology · doi:10.1002/hep.510270113 · Cited by 37
Progression through G1 and S phases of adult rat hepatocytes
Loyer, P., Ilyin, G. P., Cariou, S., Glaise, D., Corlu, A., & Guguen‐Guillouzo, C. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5873-6_4 · Cited by 37
p21 Ablation in Liver Enhances DNA Damage, Cholestasis, and Carcinogenesis
Ehedego, H., Boekschoten, M. V., Hu, W., Doler, C., Haybaeck, J., Gaβler, N., Müller, M. M., Liedtke, C., & Trautwein, C. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1356 · Cited by 34
Kato, A., Bamba, H., Shinohara, M., Yamauchi, A., Ota, S., Kawamoto, C., & Yoshida, Y. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.03829.x · Cited by 34
Zhao, X. Y., Monson, C., Gao, C., Gouon–Evans, V., Matsumoto, N., Sadler, K. C., & Friedman, S. L. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.04.018 · Cited by 36
Nagaki, M., Sugiyama, A., Naiki, T., Ohsawa, Y., & Moriwaki, H. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80401-8 · Cited by 33
The Murine Pes1 Gene Encodes a Nuclear Protein Containing a BRCT Domain
Haque, J. A., Boger, S., Li, J., & Duncan, S. A. (2000) · Genomics · doi:10.1006/geno.2000.6375 · Cited by 32
Ohlson, L. C. E., Koroxenidou, L., & Hällström, I. P. (1998) · Hepatology · doi:10.1002/hep.510270309 · Cited by 30
Hollingshead, B. D., Patel, R. D., & Perdew, G. H. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.029215 · Cited by 29
The role of p21 in regulating mammalian regeneration
Arthur, L. M., & Heber‐Katz, E. (2011) · Stem Cell Research & Therapy · doi:10.1186/scrt71 · Cited by 31
Yang, J., Zhang, W., Jiang, W., Sun, X., Yu-hua, H., Ding, M., Shi, Y., & Deng, H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008344 · Cited by 30
Hepatomegaly in transgenic mice expressing the homeobox gene Cux‐1
Heuvel, G. B. V., Nelson‐Brantley, J., Alcalay, N. I., Sharma, M., Kemeny, G., Warolin, J., Ledford, A. W., & Pinson, D. M. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20091 · Cited by 28
Immediate early genes and p21 regulation in liver of rats with acute hepatic failure
Hui, T., Mizuguchi, T., Sugiyama, N., Avital, I., Rózga, J., & Demetriou, A. A. (2002) · The American Journal of Surgery · doi:10.1016/s0002-9610(02)00822-x · Cited by 27
Shi, L., Sun, R., Wang, D., Mei-zhen, G., Su, X.-P., Yi, F., & Peng, Z. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00270 · Cited by 28
Schausberger, E. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg027 · Cited by 27
Impaired hepatocyte survival and liver regeneration in Atm-deficient mice
Lu, S., Shen, K. C., Wang, Y., Brooks, S. C., & Wang, Y. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi333 · Cited by 26
Liver regeneration, liver cancers and cyclins
Kitamura, T., Watanabe, S., & Sato, N. (1998) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.1998.13.s1.96 · Cited by 26
Gillet, R., Grimber, G., Bennoun, M., de Fromentel, C. C., Briand, P., & Joulin, V. (2000) · Oncogene · doi:10.1038/sj.onc.1203671 · Cited by 25
Cell targeting by murine retroviral vectors
Karavanas, G. (1998) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(98)00007-9 · Cited by 24
Loss of p27Kip1 accelerates DNA replication after partial hepatectomy in mice
Hayashi, E., Yasui, A., Oda, K., Nagino, M., Nimura, Y., Nakanishi, M., Motoyama, N., Ikeda, K., & Matsuura, A. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00052-0 · Cited by 24
Regulation of Cyclin D-Dependent Kinase Activity in Rat Liver Regeneration
Kato, A., Ota, S., Bamba, H., Wong, R. M., Ohmura, E., Imai, Y., & Matsuzaki, F. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8377 · Cited by 24
Liu, W.-H., Zhao, Y., Gao, S., Li, S., Cao, J., Zhang, K., & Zou, C. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091131 · Cited by 23
Sharma, S., Maras, J. S., Das, S., Hussain, S., Mishra, A. K., Shasthry, S. M., Sharma, C. B., Weiss, E., Elkrief, L., Rautou, P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-07161-4 · Cited by 22
Dominant-negative TAK1 induces c-Myc and G0exit in liver
Bradham, C. A., Hatano, E., & Brenner, D. A. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.5.g1279 · Cited by 23
Rescue of Prothrombin-deficiency by Transgene Expression in Mice
Sun, W. Y., Coleman, M. J., Witte, D. P., & Degen, S. J. F. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613344 · Cited by 22
Williams, M., Liu, X., Zhang, Y., Reske, J. J., Bahal, D., Gohl, T. G., Hollern, D. P., Ensink, E., Kiupel, M., Luo, R., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1256-x · Cited by 20
Cyclin D3 and megakaryocyte development: Exploration of a transgenic phenotype
Zimmet, J. M., Toselli, P. A., & Ravid, K. (1998) · Stem Cells · doi:10.1002/stem.5530160713 · Cited by 21
Rao, S., Gray-Bablin, J., Herliczek, T. W., & Keyomarsi, K. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4620 · Cited by 21
Expression of cyclin‐dependent kinase inhibitors, p21cip1 and p27kip1, during wound healing in rats
Zhu, X., Hu, C., Zhang, Y., Li, L., & Wang, Z. (2001) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.2001.00205.x · Cited by 19
Sphyris, N., & Harrison, D. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208249 · Cited by 19
Engidawork, E., Gulesserian, T., Seidl, R., Cairns, N. J., & Lübec, G. (2001) · Springer eBooks · doi:10.1007/978-3-7091-6262-0_14 · Cited by 19
Application of Exogenously Regulatable Promoter Systems to Transgenic Models for the Study of Aging
MORGAN, W. W., Richardson, A. G., Sharp, Z. D., & Walter, C. A. (1999) · The Journals of Gerontology Series A · doi:10.1093/gerona/54.1.b30 · Cited by 17
Garcia, M. C., Thangavel, C., & Shapiro, B. (2001) · PubMed · Cited by 17
Cell cycle attenuation by p120E4F is accompanied by increased mitotic dysfunction.
Rooney, R. J. (2001) · PubMed · Cited by 17
Poon, R. Y. C. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6199-0 · Cited by 16
Pediatric liver tumors and hepatic ontogenesis: Common and distinctive pathways
Zimmermann, A. (2002) · Medical and Pediatric Oncology · doi:10.1002/mpo.10174 · Cited by 16
Khanna, A. K., & Hosenpud, J. D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.1882 · Cited by 15
Regulation of G1 cyclin‐dependent kinases in liver regeneration
MENJO, M., Ikeda, K., & Nakanishi, M. (1998) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.1998.13.s1.100 · Cited by 15
Klocke, R., Bartels, T., Jennings, G. S., Brand, K., Halter, R., Strauss, M., & Paul, D. (2001) · The FASEB Journal · doi:10.1096/fj.00-0487fje · Cited by 14
Specific regulation of JNK signalling by the novel rat MKK7γ1 isoform
Haeusgen, W., Herdegen, T., & Waetzig, V. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.07.002 · Cited by 14
Cellular polyploidy in organ homeostasis and regeneration
Fang, J., de Bruin, A., Villunger, A., Schiffelers, R. M., Lei, Z., & Sluijter, J. P. G. (2022) · Protein & Cell · doi:10.1093/procel/pwac064 · Cited by 19
Karkoulias, G., & Flordellis, C. S. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.11.003 · Cited by 13
Clinkenbeard, E. L., Turpin, C., Jiang, J., Peterson, M. L., & Spear, B. T. (2019) · Mammalian Genome · doi:10.1007/s00335-019-09811-6 · Cited by 13
Yaʼacov, A. B., Meir, H., Zolotaryova, L., Ilan, Y., & Shteyer, E. (2017) · BMC Gastroenterology · doi:10.1186/s12876-017-0600-2 · Cited by 12
Gene Therapy and Metabolic Engineering
Wang, F., Raab, R. M., Washabaugh, M. W., & Buckland, B. C. (2000) · Metabolic Engineering · doi:10.1006/mben.1999.0144 · Cited by 12
Gene expression profiling analysis of ovarian cancer
Yin, J., Liu, X., WANG, B., WANG, D.-Y., Wei, M., Fang, H., & XIANG, M. (2016) · Oncology Letters · doi:10.3892/ol.2016.4663 · Cited by 13
Zhou, H.-P., Hughes, D., Major, M. L., Yoo, K., Pesold, C., & Costa, R. H. (2001) · Gene Expression · doi:10.3727/000000001783992597 · Cited by 14
What transgenic mice tell us about neurodegenerative disease
Gurney, M. E. (2000) · BioEssays · doi:10.1002/(sici)1521-1878(200003)22:3 · Cited by 38
Evaluation of the anti‐aging effects of Zinc‐α2‐glycoprotein peptide in clinical and in vitro study
Lee, S. G., Ham, S., Lee, J.-H., Jang, Y., Suk, J., Lee, Y. I., & Lee, J. H. (2024) · Skin Research and Technology · doi:10.1111/srt.13609 · Cited by 12
Map2k4δ — Identification and functional characterization of a novel Map2k4 splice variant
Haeusgen, W., Tüeffers, L., Herdegen, T., & Waetzig, V. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.01.028 · Cited by 11
Estrogen-Induced Proliferation in Cultured Hepatocytes Involves Cyclin D1, P21CIP1 and P27KIP1
Barone, M., Ladisa, R., Leo, A. D., Spano, D., Francioso, D., Aglio, V., Amoruso, A., Francavilla, A., & Iolascon, A. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-3173-4 · Cited by 10
Kortum, A. J., Cloup, E., Williams, T., Constantino‐Casas, F., & Watson, P. (2018) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15238 · Cited by 10
Interferon tau-induced hepatocyte apoptosis in sheep
Kim, H.-T., Stoica, G., Bazer, F. W., & OTT, T. L. (2000) · Hepatology · doi:10.1053/jhep.2000.7476 · Cited by 9
Human Cytomegalovirus-IE2 Affects Embryonic Liver Development and Survival in Transgenic Mouse
Zhang, X., Jiang, S., Zhou, X., Yu, Z., Han, S., Nan, F., Qiao, H., Niu, D., Wang, Z., Niu, J., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.05.002 · Cited by 8
Genetic, molecular, and humoral endocycle-regulating mechanisms
Shakina, L. A., & Strashnyuk, V. Y. (2011) · Russian Journal of Genetics · doi:10.1134/s1022795411100164 · Cited by 8
Transgenic animals as models for hepatocarcinogenesis
Santoni‐Rugiu, E., & Thorgeirsson, S. S. (1998) · Springer eBooks · doi:10.1007/978-94-011-4932-7_4 · Cited by 8
Roberts, R. A. (1998) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(97)00239-x · Cited by 8
Expansion of hepatic progenitor cell in fatty liver graft after living donor liver transplantation
Cho, J. Y., Suh, K., Shin, W. Y., Lee, H. W., Yi, N., Kim, M. A., Jang, J.-J., & Lee, K. U. (2010) · Transplant International · doi:10.1111/j.1432-2277.2009.01020.x · Cited by 6
Kramberger, K., Barlič‐Maganja, D., Pražnikar, Z. J., Režen, T., Rozman, D., Pražnikar, J., & Kenig, S. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115505 · Cited by 6
Stromal Cells Provide Signals Different from Cytokines for STAT5 Activation in Hematopoietic Cells.
Sato, A. K., Yanai, N., Okubo, T., Mori, K. J., & Obinata, M. (2001) · Cell Structure and Function · doi:10.1247/csf.26.95 · Cited by 6
Cellular Senescence in Acute Liver Injury: What Happens to the Young Liver?
He, K., Zhou, D., Pu, Z., Chen, S., Shen, Y., Zhao, S., Qian, X., Hu, Q., Wu, X., Xie, Z., et al. (2024) · Aging and Disease · doi:10.14336/ad.2024.0586 · Cited by 5
An efficient method to successively introduce transgenes into a given genomic locus in the mouse
Zhao, R., Fahs, S., Weiler, H., & Duncan, S. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-10 · Cited by 4
Metadata
- Authors
- Wu, H., Wade, M., Krall, L., Grisham, J., Xiong, Y., & Van Dyke, T.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1996-02-01
- Volume
- 10
- Issue
- 3
- Pages
- 245-260
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W4300612151
- Cited by
- 234
- References
- 75
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 7 · 2016: 4 · 2015: 5 · 2014: 2 · 2013: 4 · 2012: 1
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health (5r01dk042910-04)
- National Cancer Institute (R01CA065572, CA 65572, R01CA046283, CA-46283)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-42910)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- p21, cyclin-dependent kinase inhibitors, hepatocytes, postnatal liver development, liver regeneration, cell cycle arrest, cyclin D1/CDK4, hepatocyte proliferation, transgenic mice, partial hepatectomy, G2 cell cycle arrest, polyploidy, p53-independent function
- MeSH terms
- Animals, Base Sequence, Cell Cycle, Cell Division, DNA, Enzyme Inhibitors, Hepatectomy, Liver, Liver Regeneration, Mice, Transgenic, Molecular Sequence Data, Prealbumin, Proto-Oncogene Proteins, Oncogene Proteins, Cyclins, Gene Targeting, Cyclin-Dependent Kinases, Cyclin D1, Cyclin-Dependent Kinase Inhibitor p21, Cyclin-Dependent Kinase 4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review